Purchase this article with an account.
S.–J. Song, K. Kim, Y. Kim, J.–M. Seo, K. Park, S. Kim, H. Chung, H. Yu; Inhibitory Effect of YC–1 on Experimental Choroidal Neovascularization in Rat . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1418.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Purpose: To evaluate the effects of YC–1[3–(5'–hydroxymethyl–2'–furyl)–1–benzylindazole], one of the hypoxia–inducible factor–1 (HIF –1) inhibitor, on laser–induced choroidal neovascularization (CNV) in rats. Methods: Thirty female Brown–Norway rats underwent laser photocoagulation to induce CNV, and then twenty rats were treated with intraperitoneal YC–1 (3mg/kg) for two weeks. For controls, ten rats were sham–treated with DMSO. Fundus photography and fluorescein angiography were performed at 2, 3, and 4 weeks after laser.The expression of HIF–1 and VEGF at CNV was evaluated with immunohistochemistry. The size of the CNV was histologically quantified. Results: The expressions of both HIF–1 and VEGF were increased at the photocoagulation–induced CNV, but decreased in rats treated with YC–1. Treatment with YC–1 decreased the size of CNV by 60 %, compared to controls. No systemic toxicity of YC–1 was found in this study. Conclusions: These results suggest that YC–1 suppresses the development of experimental CNV by inhibiting the HIF–1 expression at the photocoagulation site.
This PDF is available to Subscribers Only